oa SA Pharmaceutical Journal - Jurnista® : hydromorphone extended-release tablets : new product focus : drug info



Osmotic controlled-release oral delivery system (OROS®) hydromorphone extended-release (Jurnista®) is a once-daily formulation of the opioid agonist hydromorphone that uses OROS® technology to deliver the analgesic at a near-constant rate over the 24-hour dosing interval. OROS® technology is used in a number of commercially available medicines, and OROS® hydromorphone was developed to provide 24-hour analgesia for severe pain, and as a result, lessen the need for breakthrough pain medication.


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error